Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
A Randomized, Two-Cohort Phase II Study of Two Doses of BMS-275183 Given on a Weekly Schedule in Patients With Pre-Treated Non-Small Cell Lung Cancer
1 other identifier
interventional
N/A
7 countries
20
Brief Summary
The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2004
CompletedFirst Posted
Study publicly available on registry
December 22, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2006
CompletedMarch 2, 2010
August 1, 2007
December 21, 2004
February 27, 2010
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Advanced or metastatic pretreated NSCLC
- Measurable disease
- Adequate hematologic, hepatic and renal functions
- ECOG Performance Status of 0-2
You may not qualify if:
- Inability to swallow capsules
- Recent significant cardiovascular disease
- Woman who are pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (20)
Local Institution
Sacramento, California, United States
Local Institution
New Haven, Connecticut, United States
Local Institution
Atlanta, Georgia, United States
Local Institution
Maywood, Illinois, United States
Local Institution
Detroit, Michigan, United States
Local Institution
Pittsburgh, Pennsylvania, United States
Local Institution
Nashville, Tennessee, United States
Local Institution
Brussels, Belgium
Local Institution
Leuven, Belgium
Local Institution
Besançon, Cedex, France
Local Institution
Saint-Herblain, Cedex, France
Local Institution
Belfort, France
Local Institution
Parma, Italy
Local Institution
Roma, Italy
Local Institution
Amsterdam, Netherlands
Local Insitution
Groningen, Netherlands
Local Institution
Barcelona, Spain
Local Institution
Madrid, Spain
Local Institution
Shefield, Yorkshire, United Kingdom
Local Institution
Manchester, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 21, 2004
First Posted
December 22, 2004
Primary Completion
March 1, 2006
Last Updated
March 2, 2010
Record last verified: 2007-08